extra articular dextrose prolotherapy and physiotherapy in ankle tendinopathy

Phase 2

Recruiting

• Conditions: Ankle Tendinopathy.; Unspecified superficial injury of ankle; S90.91

• Registration Number: IRCT20180416039323N2
• Lead Sponsor: Artesh University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

20MRI evidence of tendinopathy
conscious patient satisfaction
symptoms more than 6 month

Exclusion Criteria

rheumatological disease
diabetes
localized local infection
allergy to the drug to be injected
use of anticoagulants
INR disrupted
immunodeficiency
acute fracture

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of pain intensity. Timepoint: E??valuation of pain intensity befor ,1 and 3 month after injection or physiotherapy. Method of measurement: Cumperland outcome score questionnaire.;Functional improvement. Timepoint: Evaluation of functional improvment befor ,1 and 3 month after injection or physiotherapy. Method of measurement: Cumperland outcome score questionnaire.;Kinesiophobia. Timepoint: Befor ,1 and 3 month after injection or physiotherapy. Method of measurement: Tampa Scale for Kinesiophobia.